MedPath

FLAVIOLA Health Study

Not Applicable
Completed
Conditions
Vascular Health
Interventions
Dietary Supplement: Flavanol (410 mg)
Dietary Supplement: Control (no flavanols)
Registration Number
NCT01799005
Lead Sponsor
Heinrich-Heine University, Duesseldorf
Brief Summary

Atherosclerosis progressively occurs with increasing age in the general population. So far most dietary intervention studies with flavanols were performed over short time frames and in small groups of young healthy and older patients with manifest cardiovascular disease, respectively. Vascular health is defined as absence of vascular disease and the presence of optimal parameters that determine the development and progression of arteriosclerosis (endothelial function, blood pressure, plasma lipids, and glucose). It is not clear whether flavanols can improve parameters of vascular health, most importantly endothelial function, when given repetitively to healthy middle aged and which factors affect the efficacy of flavanol interventions.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
100
Inclusion Criteria
  • male, age 35-60 years, healthy
  • female, age 35-60 years, healthy
Exclusion Criteria
  • diabetes mellitus, acute inflammation, arrhythmia, active malignancy, terminal renal failure, signs, symptoms or medication indicative of manifest cardiovascular disease (CAD, PAD, CVD)

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
flavanol rich interventionFlavanol (410 mg)Ingestion of 410mg flavanols twice a day for 30 days
flavanol free interventionControl (no flavanols)Ingestion of a macro and micro nutrients matched flavanol free drink
Primary Outcome Measures
NameTimeMethod
Endothelial functionTime points: day 0 [baseline], and day 30 each 0 and 2h.
Secondary Outcome Measures
NameTimeMethod
Blood pressureTime points: day 0 [baseline], and day 30 each 0 and 2h.
GlucoseTime points: day 0 [baseline], and day 30 each 0 and 2h.
Plasma lipidsTime points: day 0 [baseline], and day 30 each 0 and 2h.

Trial Locations

Locations (1)

Division of Cardiology, Pulmonology and Vascular Medicine

🇩🇪

Duesseldorf, NRW, Germany

© Copyright 2025. All Rights Reserved by MedPath